Indeed, stroma-derived IGF1 enhances estrogen receptor-positive (ER+) BC cell growth and induces epithelial IGF-1 expression, leading to a more malignant phenotype (D'Esposito et al. 2012; Christopoulos et al. 2015). This evidence concerns the gene ESR1 and breast cancer.